Kinase signaling during mammary tumor initiation
Kinase signaling during mammary tumor initiation
批准号:
9751809
负责人:
Heather L Machado
金额:
$25.68万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-20 至 2022-08-31
关键词:
3-DimensionalAccountingAddressAdoptedAutocrine CommunicationBasement membraneBenignBindingBiologyBreastBreast Cancer PatientCell NucleusCell ProliferationCell SurvivalCellsClinicalCoculture TechniquesDataDevelopmentDiseaseEpidemiologyEpithelialEpithelial CellsGenesGenetic TranscriptionGoalsHumanHyperplasiaIn VitroInvadedKnowledgeLeftLesionLesion by StageLigandsMalignant NeoplasmsMammary NeoplasmsMediatingMolecularNeoplasm MetastasisNoninfiltrating Intraductal CarcinomaNuclearOncogenicOperative Surgical ProceduresParacrine CommunicationPathway interactionsPatientsPhenotypePhosphotransferasesPhysiciansPre-Clinical ModelPremalignantPrevalenceProliferatingProteomicsPublishingRadiationResearchResearch PersonnelResistanceRiskSamplingSignal TransductionSystemTestingTissuesTumor-infiltrating immune cellsXenograft Modelangiogenesisautocrinebasebreast cancer diagnosisbreast cancer progressioncancer cellcancer invasivenesscell motilityclinical practiceclinically relevantcytokinefactor Cin vivomacrophagemalignant breast neoplasmmalignant phenotypemouse modeloutcome forecastovertreatmentparacrinepersonalized carepredictive markerreceptorrecruittranscription factortumortumor initiationtumor progressiontumorigenic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Clinical and epidemiological evidence suggests that ~40% of patients with ductal carcinoma in situ (DCIS) left
untreated will progress to invasive breast cancer. However, due to our inability to distinguish lesions that will
progress to invasive cancer from those that will remain non-invasive indefinitely, all DCIS patients are treated
with surgery with or without radiation. This overtreatment dilemma demands the need for individualized patient
care based on biomarkers that predict which patients will progress. Unfortunately, very little is known about
how pre-invasive DCIS cells acquire the ability to invade the adjacent stroma, and how the stroma influences
localized invasion has not been studied. The proposed studies aim to define the molecular interactions
between infiltrating macrophages and pre-invasive epithelial cells, and uncover the mechanisms that promote
tumor development in early stage lesions. Using unique preclinical models of early progression, we show that
macrophages are recruited to pre-invasive lesions that have a high tumor-forming potential, polarized toward a
pro-tumorigenic phenotype, and secrete the cytokine Gas6. We hypothesize that macrophages recruited to
pre-invasive lesions induce cell survival and localized invasion in a Gas6-dependent manner. This hypothesis
will be tested by the following aims: Aim 1: To define the oncogenic potential of Axl during mammary tumor
initiation. Aim 2: To delineate the contribution of paracrine, autocrine and ligand-independent Axl signaling in
early stage lesions. Aim 3: To decipher Axl transcriptional regulatory mechanisms, and identify Gas6-
dependent tumor-promoting pathways. Our studies will utilize several mouse models, a unique xenograft
model of DCIS progression, and a heterotypic 3-D culture system to dissect Gas6-mediated macrophage-
epithelial crosstalk. Significance: The proposed studies will identify a mechanism by which DCIS cells
proliferate and/or invade the basement membrane, and define how the stroma promotes progression to
invasive cancer, addressing major knowledge gaps in the field of premalignancy. Recent studies suggest that
the dissemination of cancer cells occurs as early as the premalignant stage, which begs the need to
understand the mechanisms of cell migration and invasion in early stage lesions. Finally, Gas6 and Axl have
been correlated with poor overall survival and therapy resistance in a number of cancers. Our findings will
significantly advance the fields of DCIS biology and early stage breast cancer progression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functions of ductal- and stromal-associated macrophages in the mammary gland
-
批准号:10700123
-
项目类别:
-
资助金额:$48.44万
-
财政年份:2022
-
负责人:Heather L Machado
-
依托单位:
Mechanisms promoting the transition to invasive cancer
-
批准号:9674952
-
项目类别:
-
资助金额:$9.61万
-
财政年份:2018
-
负责人:Heather L Machado
-
依托单位:
Kinase signaling during mammary tumor initiation
-
批准号:9445042
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2017
-
负责人:Heather L Machado
-
依托单位:
Kinase signaling during mammary tumor initiation
-
批准号:10242663
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2017
-
负责人:Heather L Machado
-
依托单位:
Kinase signaling during mammary tumor initiation
-
批准号:10012783
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2017
-
负责人:Heather L Machado
-
依托单位:
C/EBPb Modulates Macrophages and Tumor-Initiating Cells During Preneoplastic Prog
-
批准号:8687614
-
项目类别:
-
资助金额:$22.39万
-
财政年份:2011
-
负责人:Heather L Machado
-
依托单位:
C/EBPb Modulates Macrophages and Tumor-Initiating Cells During Preneoplastic Prog
-
批准号:8331545
-
项目类别:
-
资助金额:$15.86万
-
财政年份:2011
-
负责人:Heather L Machado
-
依托单位:
C/EBPb Modulates Macrophages and Tumor-Initiating Cells During Preneoplastic Prog
-
批准号:8110438
-
项目类别:
-
资助金额:$15.86万
-
财政年份:2011
-
负责人:Heather L Machado
-
依托单位:
C/EBPb Modulates Macrophages and Tumor-Initiating Cells During Preneoplastic Prog
-
批准号:8639865
-
项目类别:
-
资助金额:$23.41万
-
财政年份:2011
-
负责人:Heather L Machado
-
依托单位:
海外基金